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ABSTRACT: The E46K genetic missense mutation of the
wild-type α-synuclein protein was recently identified in a
family of Spanish origin with hereditary Parkinson’s disease.
Detailed understanding of the structures of the monomeric
E46K mutant-type α-synuclein protein as well as the impact of
the E46K missense mutation on the conformations and free
energy landscapes of the wild-type α-synuclein are required for
gaining insights into the pathogenic mechanism of Parkinson’s
disease. In this study, we use extensive parallel tempering
molecular dynamics simulations along with thermodynamic
calculations to assess the secondary and tertiary structural
properties as well as the conformational preferences of the
monomeric wild-type and E46K mutant-type α-synuclein proteins in an aqueous solution environment. We also present the
residual secondary structure component conversion stabilities with dynamics using a theoretical strategy, which we most recently
developed. To the best of our knowledge, this study presents the first detailed comparison of the structural and thermodynamic
properties of the wild-type and E46K mutant-type α-synuclein proteins in an aqueous solution environment at the atomic level
with dynamics. We find that the E46K mutation results not only in local but also in long-range changes in the structural
properties of the wild-type α-synuclein protein. The mutation site shows a significant decrease in helical content as well as a large
increase in β-sheet structure formation upon E46K mutation. In addition, the β-sheet content of the C-terminal region increases
significantly in the E46K mutant-type αS in comparison to the wild-type αS. Our theoretical strategy developed to assess the
thermodynamic preference of secondary structure transitions indicates that this shift in secondary structure is the result of a
decrease in the thermodynamic preference of turn to helix conversions while the coil to β-sheet preference increases for these
residues. Long-range intramolecular protein interactions of the C-terminal with the N-terminal and NAC regions increase upon
E46K mutation, resulting in more compact structures for the E46K mutant-type rather than wild-type αS. However, the E46K
mutant-type αS structures are less stable than the wild-type αS. Overall, our results show that the E46K mutant-type αS has a
higher propensity to aggregate than the wild-type αS and that the N-terminal and C-terminal regions are reactive toward
fibrillization and aggregation upon E46K mutation and we explain the associated reasons based on the structural properties
herein. Small molecules or drugs that can block the specific residues forming abundant β-sheet structure, which we report here,
might help to reduce the reactivity of these intrinsically disordered fibrillogenic proteins toward aggregation and their toxicity.
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Parkinson’s disease (PD) is a debilitating neurodegenerativedisorder that affects approximately 1% of the population
above age 65 and up to 5% of the population by age 85.1 PD as
well as some other neurodegenerative disorders are charac-
terized by the formation of Lewy bodies, which are large
proteinaceous inclusions composed mainly of the intrinsically
disordered protein α-synuclein (αS).2−7 In addition, some
inherited forms of PD are associated with genetic missense or
replication mutations of the αS protein.8−11 Recently, a genetic
missense mutation of the 140 amino acid residue αS protein
resulting in the mutation of the 46th amino acid residue from
glutamic acid to lysine (E46K) was isolated in a family of
Spanish origin.8 Zarranz et al. linked this mutation to both
familial PD and Lewy body dementia.8 The aggregation of αS is
proposed to play a crucial role in the pathogenic mechanism of
PD, especially the formation of the reportedly neurotoxic
oligomeric species.12,13 Furthermore, the monomeric and
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oligomeric structures reportedly determine the aggregation
mechanism of αS.14,15
The E46K genetic missense mutation alters the aggregation
mechanism and neurotoxicity of the wild-type αS, but the
structural properties and exact impact have been debated in the
current literature. It was reported that the E46K mutant-type
αS is neurotoxic whereas the wild-type αS is neuroprotective
toward rat brains as well as for SH-SY5Y cells in the presence of
environmental toxins.16 Circular dichroism (CD), electron
microscopy, and thioflavin T (ThT) fluorescence studies as well
as sedimentation assays report that the E46K mutant-type αS
fibrillize more rapidly than the wild-type αS.17−20 However,
Kamiyoshihara et al. reported that the E46K mutant-type αS
formed fibrils at a slower rate than the wild-type αS even
though the total number of fibrils formed is greater upon E46K
mutation.21 While some experimental studies report that the
E46K mutant-type αS fibril structure is morphologically similar
to that of the wild-type αS,17−19 Choi et al. reported a more
pronounced twisted appearance for the E46K mutant-type αS
in comparison to the wild-type αS.20 Understanding the
monomeric and oligomeric wild- and mutant-type αS structures
as well as the effect of the E46K genetic missense mutation on
these structures provides knowledge directly linked to the
aggregation mechanism of αS.18,22,23 For example, specific
secondary structure component formations, such as helix and β-
sheet structures, in the structures of the monomeric intrinsically
disordered fibrillogenic proteins are known to determine the
fibrillization and aggregation mechanisms.18,24−26 Gaining
insights into these structural properties at the monomeric
level can then be used for developing therapeutic agents that
target the aggregation mechanism of αS via blocking specific
residues reactive toward aggregation. A detailed description of
the dynamic structural properties of these species remains
challenging with conventional experimental techniques due in
part to complications provided by fast aggregation, rapid
structural changes, and solvent effects. Despite, some
experimental studies have reported the structural properties
of the wild-type and E46K mutant-type αS proteins. Regarding
oligomeric structures, Fredenburg et al. reported that the
formation of protofibrillar structures decreases upon E46K
mutation of αS but that the morphological characteristics of
these structures are similar to those of its wild-type form.18
Nuclear magnetic resonance (NMR) and CD studies reported
that the secondary structure components of the free wild-type
αS protein are not greatly impacted upon E46K muta-
tion.18,19,27,28 In contrast, single molecule force (SMF)
spectroscopy measurements by Brucale et al. indicated the β-
sheet content of the E46K mutant-type αS is significantly
increased over the wild-type αS.25 NMR measurements also
indicated that interactions between the N-terminal (Met1-
Lys60) and C-terminal (Lys96-Ala140) regions are increased
upon E46K mutation of the wild-type αS.27
Theoretical studies can provide insight into the atomic level
dynamic structural changes of the wild-type αS upon E46K
mutation at the monomeric level in solution that are not easily
observable with conventional experimental tools. However,
theoretical studies investigating the E46K mutant-type αS are
mostly lacking or limited in their contents in the currently
existing literature. For example, Sundar and co-workers
reported the aggregation propensity of the E46K mutant-type
αS is intermediate of the other two genetic missense mutations
of αS via aggregation propensity calculations on structures
obtained from classical molecular dynamics (MD) simulations
in explicit water.29 Nevertheless, the impact of the E46K
mutation on the structural and thermodynamic properties of
the wild-type αS as well as sampling of conformations are not
presented in their study. Perlmutter et al. also presented
classical MD simulations of the wild-type and three genetic
missense mutant αS proteins in the presence of either an
sodium dodecyl sulfate (SDS) micelle or a phospholipid
bilayer.30 Based on these simulations, they reported that the
E46K mutation added a hydrogen bond between αS and the
lipid or micelle that may be related to the increased bilayer
affinity of E46K mutant-type αS.20,30 To the best of our
knowledge, a detailed study presenting the impact of the E46K
mutation on the structural and thermodynamic properties of
the wild-type αS in the free state at atomic level with dynamics
has not yet been presented in the literature. Therefore, we
performed all-atom replica exchange molecular dynamics
(REMD) simulations on the full-length monomeric wild-type
and E46K mutant-type αS proteins in aqueous solution. Using
these simulated structures, we calculated the secondary and
tertiary structural components as well as the thermodynamic
properties of the monomeric wild-type and E46K mutant-type
αS in an aqueous solution environment. Furthermore, we used
our recently developed new theoretical strategy for gaining
knowledge about the residual secondary structure component
conversions at the atomic level with dynamics. Based on these
results, we find that the E46K mutation greatly impacts the
structural and thermodynamic properties of the monomeric
wild-type αS in aqueous solution.
■ RESULTS AND DISCUSSION
The calculated secondary structure components per residue of
the wild-type and E46K mutant-type αS are depicted in Figure
1. Helical and β-sheet structures are proposed to play a crucial
role in the aggregation process of intrinsically disordered
fibrillogenic proteins in neurodegenerative diseases, and
therefore, these secondary structure components are of special
interest. The most abundant α-helix formation in the N-
terminal region of the wild-type αS occurs at Glu20-Gln24 with
20%−35% abundance for the wild-type αS (Figure 1). Even
though the abundance of α-helix structure of Glu20-Gln24 is
similar in the E46K mutant-type αS, the most abundant α-helix
structure in the N-terminal region of the E46K mutant-type αS
occurs at Ser9-Glu13, which is at least 15% more abundant than
Figure 1. WT and E46K αS secondary structure components.
Secondary structure abundances per residue for the wild-type
(black) and E46K mutant-type (red) αS. The abundances for the π-
helix and coil structures are not displayed.
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in the wild-type αS. Furthermore, Ala27-Ala29 and Thr54-
Thr59 also present an increase in α-helical structure upon
E46K mutation of the wild-type αS. However, the vice versa
trend is observed for residues Tyr39-Ser42. For the nonamyloid
β component region (NAC; Glu61-Val95), residues Glu61-
Thr64 of the wild-type αS protein form abundant α-helical
structure. The formation of helical structure in the N-terminal
and NAC regions is associated with lipid or vesicle binding of
the αS protein.31−34 Therefore, differences in the α-helix
formation of the αS protein as a result of the E46K mutation of
the wild-type αS may affect the binding of αS with lipids or
vesicles. Previous experimental studies reported that the E46K
mutant-type αS has a higher affinity for binding to negatively
charged vesicles than the wild-type.20 Our results support these
experiments and further show that this reported higher affinity
may be associated with the higher α-helix content at Ser9-
Glu13, Ala27-Ala29, and Thr54-Thr59 in the N-terminal region
upon E46K mutation. Within the C-terminal region (Lys96-
Ala140), the most prominent α-helix formation appears at
Lys96-Gly101 for both wild-type and E46K mutant-type αS;
however, the abundance at Gln99-Lys101 increases by up to
20% in E46K mutant-type αS rather than in the wild-type αS
conformations. In addition, the α-helical structure at Pro120-
Glu123 almost disappears upon E46K mutation in the
structures of the wild-type αS protein.
Both the wild-type and E46K mutant-type αS display
abundant 310-helix formation (>20% abundance) in the N-
terminal region at Val15-Ala18, Glu20-Thr22, Ala27-Gly31,
Gly41-Ser42, and Thr54-Lys60. Upon E46K mutation, we
observe an increase in the 310-helix formation at Ser9-Ala11,
Lys32-Glu35, and Thr54-Ala56 by up to 15%. On the other
side, the 310-helix structure formation at residues Glu46-Gly51
almost disappears when Glu46 is replaced by Lys. In the NAC
region, residues Val74-Val77 and Gly86-Ala89 of the wild-type
αS form abundant 310-helix structure (>20%). Overall, the
abundance of 310-helix structure in the NAC region decreases
upon E46K mutation except at residues Thr64, Asn65, Thr72,
Thr81-Glu83, Ala90, and Ala91. Residues Ile112-Glu114
present the most abundant 310-helix formation for both the
wild-type and E46K mutant-type αS; however, the abundance is
slightly increased for the E46K mutant-type in comparison to
the wild-type αS. We also note an increase in 310-helix
formation at Gly132-Gln134 upon E46K mutation while the
vice versa trend is observed for Pro120-Ala124 in the C-
terminal region.
For the wild-type αS, the most abundant β-sheet structures
(up to 20%) are formed in parts of the NAC and C-terminal
regions (Val70, Val71, Val82, Glu83, Ala89-Ala91, Lys102,
Asn103, Pro108, and Gln109). We also observe β-sheet
structure formation in the N-terminal region of the wild-type
αS at Phe4, Glu13, Val16, Gln24, Val26, Ala27, Thr33-Glu35,
Val37, and Val52. Interestingly, the NAC and N-terminal
residues (except Phe4) are located in regions considered part of
the 11-mer repeats. There are seven regions of 11-mer repeats,
sequences that assume right handed coiled coil conformations,
in the N-terminal and NAC region of α-synuclein.35 It is
suggested these repeats lower the propensity of α-synuclein to
form β-sheet due to their preference for α-helix formation.35 In
comparison, the most prominent β-sheet structures (20%−
50%) for the E46K mutant-type αS are located in the N-
terminal and C-terminal regions at residues Val26, Tyr39,
Gly47-Ala53, Asp119, Pro120, and Asn122-Tyr125. In addition,
Val63-Val66, Ala69-Thr72, Lys80, Gly93, Phe94, Lys96,
Glu114, Pro117, and Val118 in the NAC and C-terminal
regions present β-sheet structure formation with 5%−20%
abundances. Kessler et al. reported αS was more fibrillogenic
upon deletion of the N-terminal and C-terminal, thus implying
the NAC region is more prone to aggregation.35 In comparison
with our results, the NAC region had minor β-sheet structure
formation (5%−20% abundance), whereas the N-terminal and
C-terminal exhibited a 20%−50%. Moreover, specific residues
(Val37−Lys43, Val52−Thr59, Gln62−Val66, Gly68−Val77,
and Ala90−Val95) were reported in NMR study conducted
by Vilar et al. as the main regions to form β-sheet structures
that compose the wild-type αS fibrils.36 The most abundant (up
to 55%) turn structure formations occur in the C-terminal
region of the wild-type but this is shifted to the N-terminal
region in the E46K mutant-type αS. Large discrepancies in the
tendencies to form turn structure in the N-terminal region are
noticed at Glu13, Gly14, Ala30, Gly31, Gly36, and Lys46-
His50; in the NAC region at Val82, Ala85, and Gly86; and in
the C-terminal region at Glu110-Ile112, Pro117, Val118,
Asn122-Ala124, and Glu130, and Glu131 with a difference up
to 20%.
We also calculated the free energy change values associated
with the transitions between two different secondary structure
components for each residue of the wild-type and E46K
mutant-type αS in an aqueous solution medium (Figure 2)
using a new theoretical strategy that we most recently
developed.37 These calculations overall indicate that turn or
helix to coil transitions as well as turn to helix transitions are
the most preferred transitions for the wild-type and E46K
mutant-type α-synuclein proteins. Regarding the formation of
helical and β-sheet structures, transitions between turn to helix
structures are thermodynamically most preferred for residues
Val3-Val95 (N-terminal and NAC regions) of the wild-type αS
protein. Coil to β-sheet transitions at Phe4, Glu13, Ala90, and
Ala91 are significantly less stable upon E46K mutation of the
wild-type form. Helix to β-sheet transition per residues is
slightly more stable in parts of the N-terminal and NAC regions
in the structures of the E46K mutant-type αS in comparison to
the same regions in the wild-type αS protein. Similar
characteristics are also detected for the turn to β-sheet
conversion per residues. Interestingly, β-sheet to helix
conversion per residue with dynamics is more preferred in
parts of the N-terminal and NAC regions of the E46K mutant-
type rather than the same regions of the wild-type αS protein.
In the C-terminal region, turn to helix transitions for the wild-
type αS are more stable at Val95-Lys102, Gln109-Pro117,
Pro120-Glu123, and Glu130-Tyr133 in the E46K mutant-type
αS structures. In addition, the preferred coil to β-sheet
transitions at Lys102, Asn103, Pro108, and Gln109 in the C-
terminal region of the wild-type αS are less stable in wild-type
αS. Overall, CD and NMR measurements indicated that the
secondary structural properties of the wild-type and E46K
mutant-type αS are similar to one another.18,19,27,28 In contrast,
SMF spectroscopy measurements indicated an number of β-
sheet conformations upon E46K mutation of the wild-type
αS.25 Furthermore, E46K mutant-type αS is reported to
convert to β-sheet conformations more readily than the wild-
type αS.17,19 Our results agree with those experiments that
reported an increased β-sheet conformation for the E46K
mutant-type rather than wild-type αS.17,19,25 Moreover, we
identify that this increase in β-sheet conformation occurs in the
N-terminal and in the C-terminal regions of the E46K mutant-
type αS. The most preferred transition to a β-sheet
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conformation for these residues occurs from a coil structure
based on our thermodynamic calculations (Figure 2). The
increased β-sheet content of the E46K mutant-type αS also
agrees with the reported increased aggregation propensity of αS
upon E46K mutation that was reported by some experiments
given that the fibrillization and aggregation processes have been
related to the formation of β-sheet.17−20 Due to the proposed
importance of β-sheet formation in the aggregation process of
αS, our results indicate that residues Val26, Tyr39, Gly47-
Ala53, Asp119, Pro120, and Asn122-Tyr125 are most likely to
be involved in the fibrillization and aggregation mechanisms of
the E46K mutant-type αS. This is in contrast to the findings of
Kumar et al., who reported that residues Gly68-Ala78 and
Gly36-Gly41 have the highest aggregation propensity in the
E46K mutant-type αS.29 While some β-sheet formation occurs
in these regions in our simulated structures of the E46K
mutant-type αS, we predict the highest aggregation propensity
to be for residues Gly47-Ala53, Asp119, Pro120, and Asn122-
Tyr125.
The probability of intramolecular protein interactions
between residues in the structures of the wild-type and E46K
mutant-type αS proteins are presented in Figure 3. The NAC
and C-terminal regions of the wild-type αS protein interact
strongly (>50%) via residues Gly86-Asn103 and Glu104-
Asn122 (Figure 3, top). Strong intramolecular interactions
between the NAC and C-terminal regions of the E46K mutant-
type αS are also observed between residues Val82-Asp98 and
Glu104-Ala124 (Figure 3, bottom). In addition, an increase in
moderately abundant interactions (≤50%) between Val70-
Val82 and Glu110-Val118 as well as between Val82-Glu105 and
Glu126-Ala140 occurs upon E46K mutation. Both the wild-
type and E46K mutant-type αS present strong intramolecular
interactions with an abundance between residues Val70-Gly84
and Ala85-Leu100 within the NAC region. The E46K mutation
also results in an increase in interactions between Val48-Gly67
and Val82-Lys102 by up to 40%. Furthermore, intramolecular
interactions between the N-terminal and NAC regions (Gly7-
Val66) with the C-terminal region (Gly106-Ala140) are up to
50% more abundant in the E46K mutant-type αS than the wild-
type αS. In agreement with these findings, Rospigliosi et al.
presented that interactions between the C-terminal region with
the NAC and N-terminal regions are enhanced upon E46K
mutation of the wild-type αS.27 Interactions within the N-
terminal region are also increased in the E46K mutant-type αS
in comparison to the wild-type αS between residues Val16-
Ala30 and Gly36-Lys58. However, the weak intramolecular
Figure 2. WT and E46K αS secondary structure component transition
stability. The stability of secondary structure transitions between two
specific secondary structure components per residue for the wild-type
(WT) and E46K mutant-type (E46K) αS proteins. The color scale
corresponds to the free energy value associated with specific secondary
structure transition between two secondary structure components for a
specific residue.
Figure 3. WT and E46K αS tertiary structures. Calculated intra-
molecular interactions of the wild-type (WT) and the E46K mutant-
type (E46K) αS. The color scale corresponds to the probability (P) of
the distance between the heavy atoms (C, N, O, S) of a residue being
≤20 Å from each other.
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interactions (<10%) between the N-terminal region (Met1-
Glu20) with the NAC and C-terminal regions (Thr64-Pro120)
completely disappear upon E46K mutation of the wild-type αS
protein. Interestingly, interactions between this region of the N-
terminal (Met1-Glu20) and the NAC region have been used to
identify the two different possible vesicle binding structures.38
Experimental measurements have proposed that the αS binds
to vesicle and/or lipid structures in either a broken or extended
helical conformation that can depend on the structure of the
vesicle or lipid as well as on the protein conformation.38
Specifically, the extended helical structure is reported to more
likely bind to a flat micellar surface whereas the broken helix
structure is more likely to bond to a spherical micellar
structure.38 The broken helical structure presents a distance of
∼34 Å between the N-terminal and NAC regions whereas this
distance increases to ∼67 Å in the extended helix
conformation.38 Our reported results for the interactions
between the NAC and N-terminal regions indicate that, upon
E46K mutation, the distance is increased and therefore an
extended conformation is more likely in the E46K mutant-type
rather than wild-type αS. As a result, we predict that the E46K
mutant-type αS may show a higher binding to the flat micellar
surfaces than the wild-type whereas the vice versa trend is
expected for spherical micellar surfaces.
The radius of gyration (Rg) of a protein yields information
about the relative compactness of the overall protein structure,
which has been linked to the stability as well as the amount of
intramolecular interactions within a protein structure. Figure 4
depicts the probability distribution of the Rg values for the
structures of the wild-type and E46K mutant-type αS. Based on
this data, the probability of finding structures with Rg values
between 25.5 and 32.5 Å is higher for the E46K mutant-type
rather than wild-type αS. The vice versa trend is observed for
structures with Rg values varying between 35.5 and 55.0 Å.
Overall, these trends agree with the E46K mutant-type αS
protein having a more compact structure than the wild-type αS,
as stated above. In agreement with these findings as well as
those from the tertiary structures of these two proteins, the
increased retention time of the E46K mutant-type αS in
comparison to the wild-type αS in SEC suggests that the
conformations of the E46K mutant-type αS are more compact
than those of the wild-type αS.18 Overall, these findings suggest
that the E46K mutant-type αS structures possess a greater
number of intramolecular interactions and are more stable than
the wild-type αS structures in aqueous solution. In order to
quantitatively assess the relative stability of the wild-type and
E46K mutant-type αS structures, conformational Gibbs free
energy calculations were performed on the wild-type and E46K
mutant-type αS structures. The difference between these Gibbs
free energy values yields an estimate of the degree of difference
in the stability of the two protein structures. The average
thermodynamic values, presented in Table 1, indicate that the
conformations of the wild-type αS are thermodynamically more
stable over the structures of the E46K mutant-type αS protein
by 114.5 kJ mol−1. Additionally, the entropic (TS) and
enthalpic (H) contributions to the conformational Gibbs free
energies indicate that the wild-type αS is entropically and
enthalpically more preferred than the E46K mutant-type αS
protein by 52.5 and 61.8 kJ mol−1, respectively. The decreased
thermodynamic preference of the E46K mutant-type αS
structures in comparison to the wild-type αS conformations
indicates that the aggregation rate of the wild-type αS increases
upon E46K mutation. This result is in agreement with those
experimental studies that also reported an increased aggrega-
tion rate of the E46K mutant-type αS in comparison to the
wild-type αS.17−20
We also assessed the conformational preferences of the wild-
type and E46K mutant-type αS proteins using potential of
mean force (PMF) surfaces along the coordinates of Rg and
end-to-end distance (RE‑E), which is the distance between the
N-terminus backbone N atom and the C-terminal backbone
carboxyl C atom (Figure 5), following our previous studies on
intrinsically disordered fibrillogenic proteins.37,39,40 The PMF
surfaces determine the most favorable protein conformations
based on specific structural parameters, such as Rg and RE‑E via
capturing the solvent effects. Different intrinsically disordered
proteins structures may have similar thermodynamic properties,
which results in the presence of multiple favorable basins along
the PMF surface. Analyzing the structures in these different
basins provides insights into the conformational properties
based on specific structural parameters that influence the
favorability of the wild-type and E46K mutant-type αS
conformations in aqueous solution. The PMF surface of the
wild-type αS shows two favorable basins located at Rg values
varying between 28.0 and 35.5 Å (basin IA) and between 37.4
Figure 4. WT and E46K αS radius of gyration values. Distribution of
the radius of gyration (Rg) values of the wild-type (black) and E46K
mutant-type (red) αS for the structures obtained after convergence.
Table 1. Calculated Total Energy (Etotal), Solvation Free Energy (Gsol), Average Enthalpy (H), Entropy (TS), and Gibbs Free
Energy (G) Values for the Wild-Type and E46K Mutant-Type α-Synuclein Proteins
peptide ⟨Etotal⟩ (kJ mol
‑1) ⟨Gsol⟩ (kJ mol
‑1) ⟨H⟩ (kJ mol‑1) −T⟨S⟩ (kJ mol‑1) ⟨G⟩ (kJ mol‑1)
WT 7146.5 −16704.1 −9557.4 −7043.8 −16601.4
(±174.3) (±169.7) (±18.4) (±8.4) (±13.0)
E46K 5260.6 −14756.2 −9495.6 −6991.3 −16486.9
(±450.8) (±499.2) (±60.9) (±13.7) (±54.2)
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and 42.0 Å (basin IB) and at RE‑E values varying between 51
and 98 Å (basin IA) and between 108 and 148 Å (basin IB).
The difference in PMF values of the region between these two
basins (>1 kBT) indicates that transitions between these two
favorable PMF basins might require overriding large energy
barriers (Figure 5, top). Two favorable PMF basins are also
observed for the E46K mutant-type αS on the PMF surface
(Figure 5, bottom). The first basin (basin IA) is located at Rg
values between 25.8 and 33.2 Å and RE‑E values between 50 and
108 Å. The second favorable PMF basin (basin IB) is located at
Rg values between 33.3 and 36.4 Å and RE‑E values between 68
and 79 Å. Interestingly, the Rg and RE‑E values of basin IA are
similar for the wild-type and E46K mutant-type αS proteins;
however, the location of basin IB is shifted upon E46K
mutation of the wild-type αS. Furthermore, our results suggest
that conformational transitions these two favorable PMF basins
do not require overriding large energy barriers upon E46K
mutation. We also observe significant differences in the
secondary structural properties of the structures located in
the favorable basins for both the wild-type and E46K mutant-
type αS (Figure 6). For example, the C-terminal region of the
wild-type αS structures located in basin IA presents the most
abundant α-helix formation at residues Phe94-Gly101 (up to
56%), which is decreased by 30% in the basin IB structures
(Figure 6, top). In contrast, the most abundant α-helix
structure is observed in the N-terminal and NAC regions of
the basin IB structures of the wild-type αS at residues Glu20-
Val26, Lys32-Gly36 and Lys28-Thr64 (up to 46%). Although
α-helix structure is also present at these residues in the basin IA
structures, the abundance is 10% less than the abundance in the
basin IB wild-type αS structures. Furthermore, the α-helix
content in the N-terminal and NAC regions of the basin IA
wild-type αS structures at Met5, Lys6, Glu28, Ala29, Leu38,
Val40-Lys43, Glu61, Lys80-Glu83, and Ala89-Thr92 decreases
in the basin IB structures. Furthermore, we detect that the α-
helix abundance at Glu20-Gln24 and Lys32-Glu35 decreases
with decreasing preference along the PMF surface for the basin
IB structures (basin IB > basin II > basin III) of the wild-type
αS. The formation of 310-helix structure also varies between
structures of the two favorable PMF basins. The 310-helix
content at residues Val15-Ala17, Gly25-Gly31, Gly36-Leu38,
Val40-Ser42, Gly86-Ile88, Val95-Gln99, and Gly101 increases
by up to 40% in the basin IB structures rather than the basin IA
structures of the wild-type αS. Despite, residues Lys43-Lys45,
Gln79-Ala85, and Asp121-Tyr125 present the vice versa trend
for 310-helix abundance between the basin IA and basin IB
structures of the wild-type αS. However, we do not note any
significant trends in the 310-helix content along the PMF surface
for either favorable PMF basin. We also note large variations in
the β-sheet structure formed in the basin IA and basin IB
structures of the wild-type αS. For example, the basin IA
structures present abundant β-sheet formation (up to 22%) at
residues Val16, Gln24, Glu35, Val70, Val71, Lys102, and
Pro108. However, the basin IB structures present more
abundant β-sheet structure (up to 60%) at residues Phe4,
Glu13, Val82, Glu83, Ala90, Ala91, and Gln109. Furthermore,
the β-sheet structure at Phe4, Glu13, Val82, Glu83, Ala90, and
Ala91 of the basin IB structures decreases along the PMF
surface (basin IB > basin II > basin III).
Regarding the secondary structure components of the E46K
mutant-type αS in the two most favorable PMF basins (Figure
6B), we note that the abundant (up to 50%) α-helix formation
at Gly7-Lys12, Gly25-Glu28, Gly31-Val37, and Ala53-Glu57 in
the basin IA structures decreases by up to 20% in the basin IB
structures. On the other hand, the α-helix structure at Glu20-
Gln24, Thr72-Thr75, and Lys96-Gly101 is up to 40% more
abundant in basin IB compared to the basin IA structures.
Moreover, residues Leu8-Ala11 and Ala53-Glu57 of the basin
IA structures and Glu20-Gln24 and Lys96-Gln99 of the basin
IB structures present decreasing α-helix content along the PMF
surface (basin IA > basin II > basin III or basin IB > basin II or
basin III, respectively). The formation of 310-helix structure also
displays significant variances between the basin IA and basin IB
structures. For example, the 310-helix content at residues Ser9-
Ala11, Val15-Ala19, Gly25, Val26, Gly36-Lys45, Thr54-Ala56,
Tyr133, and Gln134 is at least 5% more abundant in the basin
IA rather than basin IB structures of the E46K mutant-type αS.
However, the basin IB structures present up to 50% more
abundant 310-helix structure at residues Ala27-Ala29, Lys32-
Glu35, Lys58-Glu61, Ala69-Glu83, Val95-Lys97, Glu110-
Glu114, and Pro128-Gly132 than in the basin IA structures.
We also note that residues Ala27-Ala29 and Lys32-Glu35
display decreasing 310-helix content along the PMF surface
while the same trend is only observed for residues Thr54-Ala56
in the basin IA structures. The formation of β-sheet structure
also presents large variations between the basin IA and basin IB
structures of the E46K mutant-type αS. The basin IB structures
present abundant (up to 85%) β-sheet structure at residues
Val26, Tyr39, Lys80, Glu83, Ala89, Ala90, Gly93, Phe94, and
Val118 that is decreased by 60% in the basin IA structures. On
Figure 5. WT and E46K αS PMF surfaces. Change in the potential of
mean force (ΔPMF) of the wild-type (WT) and E46K mutant-type
(E46K) αS along the coordinates of radius of gyrations (Rg) and end-
to-end distance (RE‑E) in units of kJ mol
−1. The reference values for
the PMF surfaces are 6.73 and 6.48 kJ mol−1 for the wild-type and
E46K mutant-type αS, respectively.
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the other side, β-sheet formation occurs at Gly47-Val52, Val63-
Val66, Ala69-Thr72, and Asp119-Glu126 with up to 62% more
abundance in the basin IA rather than basin IB structures of the
E46K mutant-type αS. Moreover, these residues also display
decreasing β-sheet content along the PMF surface for each of
their respective basins.
Notable differences in the tertiary structural properties of the
basin IA and basin IB structures of the wild-type and E46K
mutant-type αS are also evident (Figure 7). The basin IA
structures of the wild-type αS (Figure 7, top left) show
abundant intramolecular interactions between Gly86-Glu104 in
the NAC and C-terminal regions with Glu105-Ala124 in the C-
terminal region and Val70-Glu83 in the NAC region (between
50% and 95%). The N-terminal and C-terminal regions also
interact with the NAC region with up to 45% abundance via
residues Val55-Gly86 and Glu104-Tyr136. The N-terminal
(Leu8-Val16) and C-terminal (Gly132-Ala140) interactions are
also observed with low abundance (5%) in the basin IA
structures of the wild-type αS. In parallel with the basin IA
structures, the NAC and C-terminal regions of the basin IB
structures of the wild-type αS interact abundantly via residues
Thr72-Ile88 with Ile88-Val118 and residues Ala90-Asn103 with
Glu104-Pro120. However, the low abundance interactions
between residues Met1-Ala18 in the N-terminal region with the
NAC and C-terminal regions in the basin IA structures
completely disappear in the basin IB structures. Instead,
Figure 6.WT and E46K αS secondary structure components of the PMF basin structures. Calculated secondary structure abundances per residue for
the structures of the wild-type (WT) and E46K mutant-type (E46K) αS located in the basin IA (purple), basin IB (blue), basin II (green), and basin
III (red) along the PMF surface. The abundances for the π-helix and coil structures are not displayed.
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residues Met1-Lys10 interact with residues Gly14-Gly25 with
up to 40% abundance in the basin IB structures of the wild-type
αS. The tertiary structure properties of the basin IA (Figure 7,
bottom left) and basin IB (Figure 7, bottom right) structures of
the E46K mutant-type αS also display significant differences.
The highly abundant intramolecular interactions between
residues Val66-Gly106 and Ala107-Ala140 in the basin IB
structures decrease by up to 70% in the basin IA structures of
the E46K mutant-type αS. We also note the same trend for
interactions between residues Lys10-Val37 and Leu38-Lys60 as
well as between Met1-Lys10 and Val36-Val49 in the N-terminal
region of the E46K mutant-type basin IB structures. On the
other side, we observe that the interactions of residues Met1-
Asn65 with Gly106-Ala140 and residues Val48-Gly68 with
Val82-Lys102 are up to 65% more abundant in the structures of
basin IA rather than basin IB.
Herein we present the structures of the E46K mutant-type
αS and the impact of the E46K mutation on the structural and
thermodynamic properties of the wild-type αS protein in an
aqueous solution environment. The helical content of the wild-
type and E46K mutant-type αS shows an increase for a few
residues in the N-terminal and C-terminal regions but a slight
decrease in the NAC region upon E46K mutation. The
formation of β-sheet structures is significantly increased for the
E46K mutant-type αS in comparison to the wild-type αS,
especially in parts of the N-terminal and in the C-terminal
regions. This result indicates that the N-terminal and C-
terminal regions are more likely to participate in the
aggregation mechanism of the E46K mutant-type αS rather
than the wild-type αS. The use of our newly developed
theoretical strategy for identifying the thermodynamic prefer-
ence of secondary structure component transitions reveal that
helix to β-sheet as well as β-heet to helix conversions are more
stable in parts of the N-terminal and NAC regions of the E46K
mutant-type αS in comparison to the wild-type αS protein.
Moreover, coil to β-sheet conversion is more stable in parts of
the C-terminal region of the wild-type αS rather than the E46K
mutant-type αS protein. Analyses of the tertiary structures
present that the E46K mutation increases the likelihood of
long-range intramolecular interactions of the C-terminal region
with the N-terminal and NAC regions of αS. Due to the
decrease in N-terminal and NAC region interactions as well as
the increase in helical content of the N-terminal region upon
E46K mutation, our results also predict that the E46K mutant-
type αS is more likely to bind to vesicles and/or lipid
membranes in an extended helical conformation than the wild-
type αS protein. Furthermore, the tertiary structures and Rg
calculations yield that the conformations of the E46K mutant-
Figure 7. WT and E46K αS tertiary structures for the favorable PMF basin structures. Calculated intramolecular interactions of the wild-type αS
structures located in basin IA (WT IA) and basin IB (WT IB) of the PMF surface and of the E46K mutant-type αS structures located in basin IA
(E46K IA) and basin IB (E46K IB) of the PMF surface. The color scale corresponds to the probability (P) of the distance between the heavy atoms
(C, N, O, S) of a residue being ≤20 Å from each other.
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type αS are overall more compact than those of the wild-type
form. The abundant intramolecular interactions and compact-
ness of the E46K mutant-type αS, evaluation of the
conformational thermodynamic preferences of the E46K
mutant-type and wild-type αS proteins present that the E46K
mutant-type αS is structurally and thermodynamically more
stable than those of the wild-type form. Therefore, the E46K
mutant-type αS structures are more likely to aggregate than the
wild-type αS conformations, which is in agreement with some
experiments reporting similar characteristics, but here we
present the information at the atomic level with dynamics in
an aqueous solution environment. Furthermore, the PMF
surfaces of both proteins present two favorable conformational
basins with different secondary and tertiary structural proper-
ties. However, transitions between these two basins are
predicted to occur more readily for the E46K rather than the
wild-type αS due to the decreased energy barrier upon E46K
mutation of the wild-type αS. Overall, our results show that the
E46K mutation significantly impacts the structural properties of
the wild-type αS protein not only at the mutation site but also
throughout the protein structure. Furthermore, the resulting
differences in the structural and thermodynamic properties of
the wild-type αS mutation can be associated with the observed
differences in the conformational properties and aggregation
kinetics of the two αS proteins. To the best of our knowledge,
this study present the first detailed insights, at the atomic level
with dynamics in an aqueous solution environment, about the
structures of the E46K mutant-type αS and the impact of the
E46K mutation on the structures of the wild-type αS in terms
of secondary structure transition stabilities per residue and
tertiary structure properties along with conformational free
energy landscapes. The information presented herein fills the
currently existing gap in our fundamental knowledge about the
E46K mutant-type αS protein and how this mutation impacts
the wild-type form. Given that the β-sheet formation has been
linked directly to the aggregation process and toxicity of αS, we
propose that the residues we report herein with abundant β-
sheet formation should be blocked via small molecules or
antibodies to reduce the toxicity.
■ METHODS
REMD simulations enable increased conformational sampling of
protein structures by using replicas at different temperatures to
overcome energy barriers between different minimum energy
conformations of the same protein.41,42 This special sampling is
especially necessary in the case of intrinsically disordered proteins,
such as αS, which can possess numerous minimum energy
conformations due to their disordered nature. Therefore, we
performed REMD simulations on the wild-type and E46K mutant-
type full-length αS proteins using the AMBER ff99SB force field
parameters with the AMBER 11 software package.43,44 The Onufriev-
Bashford-Case Generalized Born implicit solvent model was utilized to
avoid possible errors due to confined aqueous volume and heat
capacity variations observed in explicit solvent REMD simula-
tions.39,40,45 The replica temperatures were exponentially distributed
between 283 and 490 K to yield an approximate exchange probability
of 0.70 for both simulations, resulting in a total number of 56
replicas.46 Starting from fully extended structures, the wild-type and
E46K mutant-type αS structures were equilibrated for 500 ns for each
replica. REMD simulations were then performed for a total of 40 ns
with exchanges between replicas attempted every 5 ps. The time step
was set to 2 fs, and trajectories were saved every 500 steps. The
temperature was controlled using Langevin dynamics with a collision
frequency of 2 ps−1.47,48 Long-range interactions were treated with the
particle mesh Ewald (PME) method with a cutoff value of 450 Å, and
bonds to hydrogen atoms were constrained using the SHAKE
algorithm. The convergence of both simulations was confirmed to
occur after 20 ns of simulation per replica by the cumulative secondary
structure abundance (see the Supporting Information), as shown in
our previous studies.37,39,40,49 All structural and thermodynamic
properties of the wild-type and E46K mutant-type αS were determined
from the structures obtained from the 20 ns of simulation after
convergence was reached for the replica closest to physiological
temperature (310 K). The secondary structure components of both αS
proteins were determined using the DSSP program, which includes
hydrogen bond and dihedral angle criteria.50 In addition, we analyzed
the thermodynamic preference of secondary structure transitions
between two different secondary structure components with recently
developed theoretical strategy.37 This new strategy utilizes conditional
probability to justify the potential of mean force. Specifically, the
probability of a secondary structure transition is defined as P(ti→j|Stj),
where P(ti→j) is the probability of a transition from one specific (i) to
another specific secondary structure component (j) per residue and
P(Stj) is the probability of a transition between two secondary structure
components leading to the specific formation of j for a specific residue.
The secondary structure components are defined based on hydrogen
bond and backbone dihedral angle criteria. The hydrogen bond criteria
which we implements uses the EHB = ErEtEp relationship in which the
hydrogen bond energy (EHB) depends on the spatial arrangements; the
distance-dependent energy term (Er) is calculated via Er = (A/r
8) +
(B/r6) with A = 3Er8 kcal Å8 mol−1 and B = 4Er6 kcal Å8 mol−1, where
r and E represent the hydrogen bond distance and its energy,
respectively. The angular spatial energy terms are calculated using eq
1:
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The spatial angles ti and to are computed based on the distance
deviations between the hydrogen atom and the electron lone pair
electron bisector that is located within the lone pair orbital plane and
the distance from this plane, respectively. The values K1 and K2 are
calculated via K1 = (0.9/cos
6110°) and K2 = cos
2110°, respectively.
The method that we adopt for identifying the residual secondary
structures has been used extensively. However, to the best of our
knowledge, the current literature does not include a new theoretical
strategy now a software package for determining the stability of
secondary structure component transitions. We calculate these
thermodynamic stabilities using our ProtMet software package eq 2:
λ= −k T ZPMF ln ( )B (2)
where kB is the Boltzmann constant, T is the temperature, and Z(λ) is
the ratio of the probability of transitions between two distinct
secondary structure components per residue to the probability of
overall transitions between two, three, or four components leading to
the formation of a specific residual secondary structure.
Intramolecular interactions between residues were considered to
occur if at least one heavy atom (C, O, N, S) of a specific residue was
at least ≤20 Å from any heavy atom of another residue. A cutoff
distance of 20 Å was utilized in order to account for any long-range
intramolecular interactions observed experimental from residual
dipolar coupling measurements. The thermodynamic properties of
the wild-type and E46K mutant-type αS were assessed using two
different methods: the MMPBSA method and PMF calculations.39,40,51
The MM/PBSA method calculates the conformational Gibbs free
energy (G) of each structure based on the potential energy (Etotal),
solvation free energy (Gsol), and estimated entropy (S) of each
structure at a specific temperature (T) (eq 3).52
= + −G E G TStotal sol (3)
Gsol is calculated from the sum of the electrostatic and nonpolar
contributions. In order to calculate the electrostatic contribution,
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dielectric constant values of 1 and 80 are used for the protein and
solvent environment, respectively. The entropic contribution to G was
estimated using normal-mode analysis (NMA).53 The PMF surfaces
are determined along the coordinates of radius of gyration (Rg) and




Convergence figures for the wild-type and E46K mutant-type
αS. Convergence figures for the secondary structure transition
stabilities and the PMF surfaces of both peptides. Description
of the tertiary structural properties of both peptides for the least
favorable basins on the PMF surfaces. This material is available
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